Search

Search Constraints

You searched for: Author/Creator Correa-Rocha, Rafael

Search Results

1. "First-In-Human" Clinical Trial Employing Adoptive Transfer of Autologous Thymus-Derived Treg Cells (thyTreg) to Prevent Graft Rejection in Heart-Transplanted Children. (July 2018)

2. "FIRST-IN-HUMAN" CLINICAL TRIAL EMPLOYING ADOPTIVE TRANSFER OF AUTOLOGOUS THYMUS-DERIVED TREG CELLS (THYTREG) TO PREVENT GRAFT REJECTION IN HEART-TRANSPLANTED CHILDREN. Issue 3 (September 2020)

3. 213.2: Preliminary Results of the First Clinical Trial to Prevent Graft Rejection in Heart Transplant Children Employing a Cellular Therapy With Autologous Treg Obtained From Thymic Tissue (thyTreg). (13th September 2022)

4. 213.2: Preliminary Results of the First Clinical Trial to Prevent Graft Rejection in Heart Transplant Children Employing a Cellular Therapy With Autologous Treg Obtained From Thymic Tissue (thyTreg). (13th September 2022)

5. ABO blood group is involved in the quality of the specific immune response anti-SARS-CoV-2. Issue 1 (31st December 2022)

6. ABO blood group is involved in the quality of the specific immune response anti-SARS-CoV-2. Issue 1 (31st December 2022)

7. Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain. Issue 2 (1st February 2021)

9. Induction Therapy With Basiliximab in Heart-Transplanted Children Impairs Regulatory T-Cell Population (Treg): effects on frequency, phenotype and Foxp3 expression. (May 2017)

10. Th1/Th2 Imbalance and Early Age to Transplantation is Associated to Atopic Dermatitis in Heart-Transplanted Pediatric Patients. (July 2018)